Lidocaine With Epinephrine vs. Bupivacaine With Epinephrine as Local Anesthetic Agents in Wide-awake Hand Surgery
Launched by ST. MARY'S RESEARCH CENTER, CANADA · Dec 9, 2014
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
The purpose of this study is to better understand the differences of two commonly used local anesthetics in carpal tunnel surgery. This study will explore the differences in terms of patient satisfaction during surgery (measured on VAS), pain after surgery (measured on VAS), and the need for pain medications after surgery (patients will annotate on a log given to them the time of the medication taken if needed for analgesia).
Wide awake hand surgery (freezing your limb while being fully awake) has recently been popularized as being faster and safer for patients compared to hand surgery und...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over 18 years old
- • First time carpal tunnel surgery
- Exclusion Criteria:
- • Regular analgesic medication consumption
- • More than one surgical procedure at the same time as carpal tunnel surgery
- • Need for a surrogate decision maker
- • Allergic or unable to take morphine, hydromorphone (Dilaudid), acetaminophen (Tylenol), lidoxaine (Xylocaine), bupivacaine (Marcane), or epinephrine
- • End stage kidney disease
- • End stage liver disease
- • Pregnant
About St. Mary's Research Center, Canada
St. Mary's Research Center, located in Canada, is a leading institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Committed to fostering collaboration among healthcare professionals, researchers, and industry partners, the center focuses on a diverse range of therapeutic areas, including cardiology, neurology, and oncology. With a robust infrastructure and a patient-centered approach, St. Mary's Research Center aims to translate scientific discoveries into practical applications, enhancing treatment outcomes and contributing to the overall health of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montreal, Quebec, Canada
Patients applied
Trial Officials
Mario Luc, MD, FRCSC
Principal Investigator
McGill University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials